| TU price | $9.56 at the July 31, 2026 close, down 11.23% on the day | StockAnalysis.com real-time quote | August 2, 2026 |
| Market capitalization | $15.01 billion, computed as $9.56 x 1.57 billion shares outstanding with 0.01% deviation | StockAnalysis.com quote and statistics | August 2, 2026 |
| Q2 2026 net loss and impairment | Net loss of C$1.83 billion versus a C$245 million loss a year ago, driven by a C$2.1 billion pre-tax non-cash intangible asset and goodwill impairment of the TELUS Digital cash-generating unit | TELUS Q2 2026 earnings release | July 31, 2026 |
| Q2 2026 revenue and margins | Operating revenues of C$4.92 billion down 2%, consolidated service revenue of C$4.4 billion down 1%, adjusted EBITDA of C$1.78 billion down 2% | TELUS Q2 2026 earnings release | July 31, 2026 |
| Q2 2026 earnings per share | Adjusted EPS of C$0.16, down 27% from C$0.22 a year ago, with negative basic EPS due to the impairment | TELUS Q2 2026 earnings release and call | July 31, 2026 |
| Q2 2026 cash flow | Cash provided by operating activities of C$1.34 billion up 15%, free cash flow of C$545 million up 2%, capital expenditures of C$678 million | TELUS Q2 2026 earnings release | July 31, 2026 |
| Dividend reset | Quarterly dividend reset 55% to C$0.1875 per share, annualized C$0.75 versus C$1.6736 previously, effective October 1, 2026, with about C$2.7 billion of cumulative cash savings through 2028 and the DRIP discount removed | TELUS Q2 2026 earnings release and call | July 31, 2026 |
| FY2026 revised guidance | Service revenue flat to negative 2% (from 2% to 4% growth), adjusted EBITDA negative 2% to negative 4% (from 2% to 4% growth), free cash flow about C$1.8 billion (from about C$2.45 billion), capital expenditures about C$2.6 billion (from about C$2.3 billion), with an incremental C$100 million in restructuring costs | TELUS Q2 2026 earnings release and call | July 31, 2026 |
| Leverage and balance sheet plan | Net debt to adjusted EBITDA of 3.5x at June 30, 2026, down from 3.7x a year ago, targeting 3.0x or lower by year-end 2028, with total available liquidity of C$2.7 billion and a payout ratio target of 45% to 60% of free cash flow from 2027 | TELUS Q2 2026 earnings call | July 31, 2026 |
| Q2 2026 segment results | TELUS Technology Solutions service revenue of C$3.3 billion and adjusted EBITDA of C$1.6 billion flat, mobile network revenue of C$1.7 billion up 1%, fixed data services stable at C$1.2 billion, TELUS Health service revenue of C$533 million up 4%, TELUS Digital revenue down 10%, Agriculture and Consumer Goods service revenue of C$90 million up 6% | TELUS Q2 2026 earnings release and call | July 31, 2026 |
| Subscriber metrics | Mobile phone net additions of 17,000, internet net additions of 20,000, connected device net additions of 187,000, blended mobile phone churn of 1.08%, and mobile phone ARPU of C$56.36 declining 0.4% | TELUS Q2 2026 earnings release | July 31, 2026 |
| Free cash flow growth commitment | Management committed to a minimum 10% compounded annual free cash flow growth over 2027 and 2028 off the lower 2026 base of about C$1.8 billion | TELUS Q2 2026 earnings call | July 31, 2026 |
| TELUS Digital impairment detail | The C$2.1 billion impairment reflects faster-than-expected automation of legacy content moderation, ad relevancy, and search services for hyperscale clients, extended sales cycles, and compressed deal sizes, with CX AI now more than half of TELUS Digital revenue | TELUS Q2 2026 earnings call | July 31, 2026 |
| Asset monetization | Active review of non-core assets including parts of TELUS Health, non-real-estate assets, and the TELUS Ventures portfolio; the Terrion tower sale of a 49.9% stake to La Caisse in September 2025 generated C$1.26 billion of proceeds | TELUS Q2 2026 earnings call | July 31, 2026 |
| Securities offering filing | TELUS filed registration statements with the SEC on July 31, 2026 related to a securities offering, per the StockAnalysis.com filings feed | StockAnalysis.com filings feed | July 31, 2026 |
| FY2025 full-year results | Revenue of C$20.35 billion up 1.03% from C$20.14 billion, net income of C$1.11 billion up 12%, and free cash flow of C$2.35 billion | StockAnalysis.com financials, S&P Global | August 2, 2026 |
| TTM results as of June 30, 2026 | Revenue of C$20.21 billion down 1.06%, net income of negative C$919 million, and free cash flow of C$2.40 billion | StockAnalysis.com financials, S&P Global | August 2, 2026 |
| Balance sheet as of June 30, 2026 | Cash and investments of C$1.39 billion, total debt of C$31.46 billion, and net debt of about C$30.07 billion on the StockAnalysis.com balance sheet | StockAnalysis.com balance sheet | August 2, 2026 |
| Valuation snapshot | 22.58x trailing GAAP EPS, 14.18x forward earnings, 1.03x sales, 1.28x book value, 9.48x free cash flow, 9.69x EV/EBITDA, and an Altman Z-Score of 0.89 | StockAnalysis.com statistics | August 2, 2026 |
| Analyst consensus | Hold rating across 18 analysts with an average target of $14.17, a low of $12, a median of $14.50, and a high of $16 | StockAnalysis.com forecast, S&P Global and TipRanks | August 2, 2026 |
| Analyst rating mix, July 2026 | 4 Strong Buy, 3 Buy, 8 Hold, 1 Sell, and 2 Strong Sell out of 18 | StockAnalysis.com forecast recommendation trends | August 2, 2026 |
| Recent analyst actions | CIBC downgraded to Hold with a target cut from $17 to $11 on July 31, Morgan Stanley downgraded to Sell with a target cut from $14 to $9.24 on July 21, Barclays moved from $14 to $12 on July 16, and TD Cowen maintained Buy at $14 on July 22 | StockAnalysis.com forecast | August 2, 2026 |
| Technical snapshot | 5-day SMA near $10.51, 20-day SMA near $10.40, 50-day SMA near $11.25, 100-day SMA near $11.95, 200-day SMA near $12.87, 14-day RSI near 32.5, 14-day ADX near 37.8, and 14-day historical volatility near 57% | Barchart and StockAnalysis.com technical snapshots | August 2, 2026 |
| Short interest | 66.9 million shares short, 4.25% of shares outstanding, and 11.1 days to cover | StockAnalysis.com statistics short selling | August 2, 2026 |
| Price history | 52-week range of $9.22 to $16.72, down about 41% over the past 52 weeks, with a beta near 0.74 | StockAnalysis.com quote | August 2, 2026 |